English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Global: Zendy Plus annual

Presents the access of premium content as premium feature

Premium Content

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Global: Zendy Tools annual

Global: Zendy Free Plan

Global: Zendy Tools monthly

Global: Zendy Plus monthly

The morbidity of uterine leiomyomas is more than 70%, and 62% of women will enter menopause with leiomyomas (1,2). The treatment of uterine leiomyomas depends on the size, quantity, clinical symptoms, fertility requirements, and patients’ subjective wishes. Myomectomy or hysterectomy is the most commonly used method of traditional treatment, but for women who require conservative treatment or fertility requirements, the pursuit of the best treatment options is particularly important. At present, non-traditional surgical treatments, such as gonadotropinOriginal Article

Selective estrogen receptor modulator with estrogen does not affect the proliferation and apoptosis of uterine leiomyoma cells